Your session is about to expire
← Back to Search
Tranexamic Acid for Surgical Bleeding Control
Study Summary
This trial will compare the need for DHA when TXA is administered during orthognathic surgery. DHA has risks, so it may be safer to avoid it if TXA can control blood loss and provide good surgical site visualization.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I had jaw surgery at UAB Highlands Hospital.I have a bleeding disorder.I have a history of high blood pressure or heart issues.I cannot take TXA due to medical reasons.
- Group 1: Patients Receiving Tranexamic Acid with Avoidance of Hypotensive Anesthesia
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is it still possible to enroll in this research program?
"According to clinicaltrials.gov, this trial has concluded its recruitment process and is no longer actively seeking patients. The initial post was made on December 1st 2022 with the last edit occurring on August 15th 2022. Fortunately, there are presently 129 different medical studies that need new participants."
Who can sign up for this medical research experiment?
"This study seeks 50 volunteers aged 12 to 75 with hypotension that have had bimaxillary orthognathic surgery at UAB Highlands Hospital."
Is the age limit for enrollment in this experiment higher than seventy-five years?
"This medical trial is accepting participants who have surpassed the age of 12 and are below 75 years old."
Has the FDA endorsed TRANEXAMIC ACID 1 G in 10 mL INTRAVENOUS INJECTION, SOLUTION?
"Owing to the Phase 4 status of TRANEXAMIC ACID 1 G in 10 mL INTRAVENOUS INJECTION, SOLUTION and its approval for use, our team has assigned it a 3 on their safety scale."
Share this study with friends
Copy Link
Messenger